Nanoparticle-Based Approaches to Targeting Drugs for Severe Diseases
Author:   Dr. Jose L. Arias
Publisher:   Elsevier Science & Technology
Volume:   No. 47
ISBN:  

9781907568114


Pages:   300
Publication Date:   01 January 2013
Format:   Hardback
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Our Price $323.44 Quantity:  
Add to Cart

Share |

Nanoparticle-Based Approaches to Targeting Drugs for Severe Diseases


Overview

Full Product Details

Author:   Dr. Jose L. Arias
Publisher:   Elsevier Science & Technology
Imprint:   Woodhead Publishing Ltd
Volume:   No. 47
Weight:   0.454kg
ISBN:  

9781907568114


ISBN 10:   1907568115
Pages:   300
Publication Date:   01 January 2013
Audience:   General/trade ,  Professional and scholarly ,  General ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

Integration of nanotechnology in pharmacotherapy; Nanostructures in drug delivery; Nano-engineering strategies for passive drug delivery and targeting; Nano-engineering strategies for ligand-mediated drug delivery and targeting; Nano-engineering strategies for stimuli-sensitive drug delivery and targeting; Nano-engineering strategies in theragnosis; Advanced nanomedicines against severe diseases.

Reviews

Author Information

Dr Jose L. Arias is an assistant professor of Pharmaceutical Technology, Clinical Pharmacy, and Drug Delivery, as well as Biopharmacy and Pharmacokinetics, at the Department of Pharmacy and Pharmaceutical Technology in the University of Granada, Spain. He has also worked as Associate Researcher of UMR CNRS 8612 'Physico-chimie, Pharmacotechnie et Biopharmacie' at the Universite Paris-Sud, France. His research group is actively involved in the development of colloidal drug delivery systems against severe diseases (cancer, autoimmune diseases, infectious diseases, etc.). His area of specialization includes a focus on the formulation of advanced drug nanocarriers on the basis of passive and active targeting strategies. More recently, he has commenced work on engineering strategies for the preparation of theragnostic nanoparticles.

Tab Content 6

Author Website:  

Countries Available

All regions
Latest Reading Guide

NOV RG 20252

 

Shopping Cart
Your cart is empty
 Shopping cart
Mailing List

 

Sign up now